Indigo Therapeutics To Open Concentrated Cannabis Manufacturing Plant In Richmond, California
07/21/2016
According to company officials, Richmond City Council voted unanimously to grant the first license for the legal manufacture of concentrated cannabis in California to Indigo Therapeutics, a legal cannabis company owned by Landrace Venture Fund. The license allows Indigo to begin producing cannabis concentrates immediately in quantities that make the company the state's largest manufacturer of concentrates.
"We're thrilled about the opportunities this license opens to provide medical marijuana patients with legal, consistent, and pure concentrates and edibles," said Joe Hawayek of Indigo Therapeutics. Cannabis concentrates and edibles are the largest and fastest growing segments of the cannabis market. "Consumers will now be able to trust that their products are pure, consistent, and of the highest quality," said Hawayek.
Professional extraction and refinement establishes product purity, safety, and dosage control and promises to be the most valuable link in the supply chain for legal cannabis, officials said.
"We are excited that Landrace Ventures and Indigo are leading the way in Richmond," said the Mayor of Richmond, Tom Butt. "With the California legislature clarifying the State's legal context for cannabis cultivation and product manufacturing last year, cities can now proceed to issue permits for such operations without risk.”
"These businesses, when properly regulated and operated in designated locations, can be low impact and provide good jobs and revenue for the City of Richmond,” he added.
"We have worked closely with the City of Richmond and other local and state officials to ensure that all communities are heard and satisfied," said Hawayek. "Our goal is to bring professionalism to the marketplace and be the standard of quality and consistency."
Landrace Venture Fund was established earlier this year to invest in legal and scalable cannabis infrastructure. "We're looking carefully for opportunities in the medical and recreational markets," said Scott Lucas, one of the Fund's founding partners. "We see enormous potential for refined, quality-controlled cannabis in pharmaceuticals for chronic pain management, sleep, diet, epilepsy, arthritis, and as an alternative to over prescribed opioids."
Project Announcements
US Forged Rings Plans Hertford County, North Carolina, Steel Component Operations
03/02/2026
South Korea-Based Hanjung America Plans Huntington, Indiana, Manufacturing Operations
03/02/2026
Faith Technologies Plans Opelika, Alabama, Manufacturing Operations
03/01/2026
TaylorMade Golf Expands Vanderburgh County, Indiana, Distribution Operations
03/01/2026
Sediver USA Expands West Memphis, Arkansas, Operations
03/01/2026
Carpenter Pole and Piling Expands Wiggins, Mississippi, Operations
03/01/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025